Suppr超能文献

心肌细胞作为心脏损伤中细胞因子的来源

The Cardiomyocyte as a Source of Cytokines in Cardiac Injury.

作者信息

Aoyagi Toshinori, Matsui Takashi

机构信息

Center for Cardiovascular Research, John A. Burns School of Medicine, University of Hawaii, Honolulu, HI 96813.

出版信息

J Cell Sci Ther. 2011 Dec 1;2012(S5). doi: 10.4172/2157-7013.s5-003.

Abstract

Fibrosis induced by prolonged inflammation is a major pathophysiological feature of adverse left ventricular remodeling after myocardial infarction and pathological cardiac hypertrophy. Recent reports strongly suggest that the interaction between leukocytes, non-myocytes (mainly cardiac fibroblasts) and cardiomyocytes, possibly mediated by cytokine signaling, plays an important role in controlling the inflammatory reaction after cardiac injury. Therefore, controlling cytokine secretion from resident cardiomyocytes is one plausible strategy for preventing tissue damage.

摘要

长期炎症诱导的纤维化是心肌梗死后不良左心室重构和病理性心脏肥大的主要病理生理特征。最近的报告有力地表明,白细胞、非心肌细胞(主要是心脏成纤维细胞)和心肌细胞之间的相互作用,可能由细胞因子信号介导,在控制心脏损伤后的炎症反应中起重要作用。因此,控制驻留心肌细胞的细胞因子分泌是预防组织损伤的一种可行策略。

相似文献

1
The Cardiomyocyte as a Source of Cytokines in Cardiac Injury.
J Cell Sci Ther. 2011 Dec 1;2012(S5). doi: 10.4172/2157-7013.s5-003.
2
Mst1/Hippo signaling pathway drives isoproterenol-induced inflammatory heart remodeling.
Int J Med Sci. 2024 Jul 1;21(9):1718-1729. doi: 10.7150/ijms.95850. eCollection 2024.
3
CITED4 Protects Against Adverse Remodeling in Response to Physiological and Pathological Stress.
Circ Res. 2020 Aug 14;127(5):631-646. doi: 10.1161/CIRCRESAHA.119.315881. Epub 2020 May 18.
6
Ablation of biglycan attenuates cardiac hypertrophy and fibrosis after left ventricular pressure overload.
J Mol Cell Cardiol. 2016 Dec;101:145-155. doi: 10.1016/j.yjmcc.2016.10.011. Epub 2016 Oct 24.
7
Stromal Cell-SLIT3/Cardiomyocyte-ROBO1 Axis Regulates Pressure Overload-Induced Cardiac Hypertrophy.
Circ Res. 2024 Mar 29;134(7):913-930. doi: 10.1161/CIRCRESAHA.122.321292. Epub 2024 Feb 27.
10
Targeting WWP1 ameliorates cardiac ischemic injury by suppressing KLF15-ubiquitination mediated myocardial inflammation.
Theranostics. 2023 Jan 1;13(1):417-437. doi: 10.7150/thno.77694. eCollection 2023.

引用本文的文献

1
Matrisome remodeling in the myocardium of hypertrophic cardiomyopathy; novel targets for molecular diagnostics.
Front Cell Dev Biol. 2025 Aug 6;13:1641584. doi: 10.3389/fcell.2025.1641584. eCollection 2025.
2
Cardiac alterations induced by Trypanosoma cruzi extracellular vesicles and immune complexes.
PLoS Negl Trop Dis. 2025 Jul 7;19(7):e0013273. doi: 10.1371/journal.pntd.0013273. eCollection 2025 Jul.
3
Immunization induces inflammation in the mouse heart during spaceflight.
BMC Genomics. 2025 Mar 10;26(1):229. doi: 10.1186/s12864-025-11426-y.
4
Systemic aging fuels heart failure: Molecular mechanisms and therapeutic avenues.
ESC Heart Fail. 2025 Apr;12(2):1059-1080. doi: 10.1002/ehf2.14947. Epub 2024 Jul 22.
5
Early- to mid-gestational testosterone excess leads to adverse cardiac outcomes in postpartum sheep.
Am J Physiol Heart Circ Physiol. 2024 Aug 1;327(2):H315-H330. doi: 10.1152/ajpheart.00763.2023. Epub 2024 May 31.
6
Cardiac hypertrophy that affects hyperthyroidism occurs independently of the NLRP3 inflammasome.
Pflugers Arch. 2024 Jul;476(7):1065-1075. doi: 10.1007/s00424-024-02965-6. Epub 2024 Apr 29.
10
The direct effect of lipopolysaccharide on an isolated heart is different from the effect on cardiac myocytes .
Arch Med Sci. 2019 Aug 2;19(1):216-228. doi: 10.5114/aoms.2019.86976. eCollection 2023.

本文引用的文献

1
Complement dependency of cardiomyocyte release of mediators during sepsis.
FASEB J. 2011 Jul;25(7):2500-8. doi: 10.1096/fj.11-183236. Epub 2011 Apr 8.
2
Inflammation and cardiac outcome.
Curr Opin Infect Dis. 2011 Jun;24(3):259-64. doi: 10.1097/QCO.0b013e328344f50f.
3
Inflammasome activation of cardiac fibroblasts is essential for myocardial ischemia/reperfusion injury.
Circulation. 2011 Feb 15;123(6):594-604. doi: 10.1161/CIRCULATIONAHA.110.982777. Epub 2011 Jan 31.
4
mTOR attenuates the inflammatory response in cardiomyocytes and prevents cardiac dysfunction in pathological hypertrophy.
Am J Physiol Cell Physiol. 2010 Dec;299(6):C1256-66. doi: 10.1152/ajpcell.00338.2010. Epub 2010 Sep 22.
5
Direct reprogramming of fibroblasts into functional cardiomyocytes by defined factors.
Cell. 2010 Aug 6;142(3):375-86. doi: 10.1016/j.cell.2010.07.002.
6
Interleukin 6 mediates myocardial fibrosis, concentric hypertrophy, and diastolic dysfunction in rats.
Hypertension. 2010 Aug;56(2):225-31. doi: 10.1161/HYPERTENSIONAHA.109.148635. Epub 2010 Jul 6.
7
TNFα in myocardial ischemia/reperfusion, remodeling and heart failure.
Heart Fail Rev. 2011 Jan;16(1):49-69. doi: 10.1007/s10741-010-9180-8.
9
Proinflammatory cytokines in heart failure: double-edged swords.
Heart Fail Rev. 2010 Nov;15(6):543-62. doi: 10.1007/s10741-010-9168-4.
10
Antibody against interleukin-6 receptor attenuates left ventricular remodelling after myocardial infarction in mice.
Cardiovasc Res. 2010 Aug 1;87(3):424-30. doi: 10.1093/cvr/cvq078. Epub 2010 Mar 7.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验